Almost every cell in the body carries microscopic, hair-like projections called cilia, and disruptions in the genes that build and run them can affect multiple organs simultaneously — this is the underlying basis of a group of disorders called ciliopathies, of which Bardet-Biedl Syndrome (BBS) is a well-documented example. Vision loss is a near-universal feature of BBS, though it sits alongside a broader constellation of findings that most patients are already being managed for by the time a retina evaluation is requested.
Given how many systems BBS can touch, our own contribution stays purposefully narrow: we review whatever medical history is available to understand the wider clinical picture, and reserve the actual consultation for the retinal testing and planning that requires dedicated ophthalmic equipment.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
” No — our assessment and any treatment we offer are confined entirely to the eye. Weight and kidney management stay with the specialists already handling those aspects of care, and we’re glad to coordinate and share findings with them as needed.
”
”
It often does — central vision tends to be affected earlier in BBS than in non-syndromic RP, which is part of why we recommend a tighter monitoring schedule specifically for patients with BBS.”
” Yes, definitely. A baseline ERG and OCT before any symptoms surface gives us a reference point to measure against later, and lets us plan for low-vision support in advance rather than only responding once problems appear.”
“The wider medical history is genuinely useful in helping us understand the full picture of the syndrome, even though the consultation itself concentrates specifically on the retinal assessment.”
